XTalks

FEBRUARY 8, 2024

According to AstraZeneca, the drug had strong demand across all of its approved indications and was further supported by recent guideline updates from cardiology societies. In its 2022 financial report, Sanofi reported that sales of the long-acting insulin dropped 27.6 This performance exceeded Wall Street’s expectations by 20 percent.

Sales 52

Sales Insulin FDA Approval Drugs 52

Delveinsight

DECEMBER 29, 2020

Food and Drug Administration has given a green signal to the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia. . It is a complication associated with diabetic patients who take insulin and certain anti-diabetic tablets.

Trials 52

Trials Drugs Hormones Radiology 52

XTalks

AUGUST 2, 2023

2) Paxlovid (nirmatrelvir/ritonavir) Paxlovid is a dual-packaged oral medication for the treatment of COVID-19. It is a dipeptidyl peptidase-4 inhibitor that keeps insulin levels stable and reduces the amount of glucose produced by the body. a month for either 150 mg or 300 mg dose strength packages, and $3,462.13 billion ($8.72

Sales 98

Sales Manufacturing FDA Approval Life Science 98